1. A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer. (23rd March 2019) Authors: Veeraraghavan, J; Angelis, C De; Mao, R; Wang, T; Herrera, S; Pavlick, A C; Contreras, A; Nuciforo, P; Mayer, I A; Forero, A; Nanda, R; Goetz, M P; Chang, J C; Wolff, A C; Krop, I E; Fuqua, S A W; Prat, A; Hilsenbeck, S G; Weigelt, B; Reis-Filho, J S Journal: Annals of oncology Issue: Volume 30:Number 6(2019) Page Start: 927 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparison of the two time schedules for endoscopic sclerotherapy: a prospective randomised controlled study. Issue 6 (June 1986) Authors: Sarin, S K; Sachdev, G; Nanda, R; Batra, S K; Anand, B S Journal: Gut Issue: Volume 27:Issue 6(1986) Page Start: 710 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Endoscopic sclerotherapy using absolute alcohol. Issue 2 (February 1985) Authors: Sarin, S K; Sachdeva, G K; Nanda, R; Vij, J C; Anand, B S Journal: Gut Issue: Volume 26:Issue 2(1985) Page Start: 120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Food intolerance and the irritable bowel syndrome. Issue 8 (August 1989) Authors: Nanda, R; James, R; Smith, H; Dudley, C R; Jewell, D P Journal: Gut Issue: Volume 30:Issue 8(1989) Page Start: 1099 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Intravariceal versus paravariceal sclerotherapy: a prospective, controlled, randomised trial. Issue 6 (June 1987) Authors: Sarin, S K; Nanda, R; Sachdev, G; Chari, S; Anand, B S; Broor, S L Journal: Gut Issue: Volume 28:Issue 6(1987) Page Start: 657 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Measurement and correlation of wedged hepatic, intrahepatic, intrasplenic and intravariceal pressures in patients with cirrhosis of liver and non-cirrhotic portal fibrosis. Issue 3 (March 1987) Authors: Sarin, S K; Sethi, K K; Nanda, R Journal: Gut Issue: Volume 28:Issue 3(1987) Page Start: 260 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program. Issue 1 (4th April 2017) Authors: McKillip, RP; Borden, BA; Galecki, P; Ham, SA; Patrick‐Miller, L; Hall, JP; Hussain, S; Danahey, K; Siegler, M; Sorrentino, MJ; Sacro, Y; Davis, AM; Rubin, DT; Lipstreuer, K; Polonsky, TS; Nanda, R; Harper, WR; Koyner, JL; Burnet, DL; Stadler, WM Journal: Clinical pharmacology & therapeutics Issue: Volume 102:Issue 1(2017) Page Start: 106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study. (26th November 2018) Authors: Adams, S; Schmid, P; Rugo, H S; Winer, E P; Loirat, D; Awada, A; Cescon, D W; Iwata, H; Campone, M; Nanda, R; Hui, R; Curigliano, G; Toppmeyer, D; O'Shaughnessy, J; Loi, S; Paluch-Shimon, S; Tan, A R; Card, D; Zhao, J; Karantza, V Journal: Annals of oncology Issue: Volume 30:Number 3(2019) Page Start: 397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study. (26th November 2018) Authors: Adams, S; Loi, S; Toppmeyer, D; Cescon, D W; De Laurentiis, M; Nanda, R; Winer, E P; Mukai, H; Tamura, K; Armstrong, A; Liu, M C; Iwata, H; Ryvo, L; Wimberger, P; Rugo, H S; Tan, A R; Jia, L; Ding, Y; Karantza, V; Schmid, P Journal: Annals of oncology Issue: Volume 30:Number 3(2019) Page Start: 405 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pharmacogenomics‐Based Point‐of‐Care Clinical Decision Support Significantly Alters Drug Prescribing. Issue 5 (15th June 2017) Authors: O'Donnell, PH; Wadhwa, N; Danahey, K; Borden, BA; Lee, SM; Hall, JP; Klammer, C; Hussain, S; Siegler, M; Sorrentino, MJ; Davis, AM; Sacro, YA; Nanda, R; Polonsky, TS; Koyner, JL; Burnet, DL; Lipstreuer, K; Rubin, DT; Mulcahy, C; Strek, ME Journal: Clinical pharmacology & therapeutics Issue: Volume 102:Issue 5(2017) Page Start: 859 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗